Reference,Reference: DOI,Assay,Section,Infection (CP),Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,164.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,<,20.0,1.0,>,8.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,330.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,<,20.0,1.0,>,16.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,228.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,=,56.0,1.0,=,4.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,286.0,1.0,Beta,18,L18F + D80A + D215G + Δ241-244 + K417N + E484K + N501Y + A701V,1,<,20.0,1.0,>,14.3